Drugs / CD4+/CD25+ cells
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00176930 Background | Oct 2001 → Dec 2019 | Hodgkins lymphoma, acute myeloid leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, chronic myeloid leukemia +3 | Masonic Cancer Center, University of Minnesota | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD4+/CD25+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00176930 ↗ |
| Route | Intravenous | “CD4+/CD25+ cells intravenously” NCT00176930 ↗ |